171 related articles for article (PubMed ID: 37187496)
1.
Menakuru SR; Roepke J; Siddiqui S
J Hematol; 2023 Apr; 12(2):82-86. PubMed ID: 37187496
[TBL] [Abstract][Full Text] [Related]
2. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
Moccia F; Casti P; Morra L
Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
[TBL] [Abstract][Full Text] [Related]
3. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.
Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W
Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632
[TBL] [Abstract][Full Text] [Related]
4. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
5. De novo chronic lymphocytic leukemia/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase.
Chowdhury Z; Khonglah Y; Sarma S; Kalita P
Autops Case Rep; 2021; 11():e2020196. PubMed ID: 34277479
[TBL] [Abstract][Full Text] [Related]
6. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
Schlette E; Bueso-Ramos C; Giles F; Glassman A; Hayes K; Medeiros LJ
Am J Clin Pathol; 2001 Apr; 115(4):571-81. PubMed ID: 11293906
[TBL] [Abstract][Full Text] [Related]
7. B-prolymphocytic leukemia: Is it time to retire this entity?
El Hussein S; Khoury JD; Medeiros LJ
Ann Diagn Pathol; 2021 Oct; 54():151790. PubMed ID: 34293709
[TBL] [Abstract][Full Text] [Related]
8. A T-cell prolymphocytic leukemia case with central nervous system involvement.
Malkan UY; Gunes G; Yayar O; Demiroglu H; Yesilirmak A; Uner A
Int J Clin Exp Med; 2015; 8(8):14207-9. PubMed ID: 26550397
[TBL] [Abstract][Full Text] [Related]
9. An Unusual Case of Prolymphocytic Leukemia Transformation in a Patient With Chronic Lymphocytic Leukemia.
Bell S; Lattanzio N; Braham J; Campdesuner V; Abdelal Q; Vartanov A; Pelayo M
J Investig Med High Impact Case Rep; 2021; 9():2324709621990767. PubMed ID: 33533282
[TBL] [Abstract][Full Text] [Related]
10. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
[TBL] [Abstract][Full Text] [Related]
11. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
Flatley E; Chen AI; Zhao X; Jaffe ES; Dunlap JB; Pittaluga S; Abdullah S; Olson SB; Spurgeon SE; Fan G
Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
[TBL] [Abstract][Full Text] [Related]
13. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
15. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
17. B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma.
van der Velden VH; Hoogeveen PG; de Ridder D; Schindler-van der Struijk M; van Zelm MC; Sanders M; Karsch D; Beverloo HB; Lam K; Orfao A; Lugtenburg PJ; Böttcher S; van Dongen JJ; Langerak AW; Kappers-Klunne M; van Lom K
Blood; 2014 Jul; 124(3):412-9. PubMed ID: 24891323
[TBL] [Abstract][Full Text] [Related]
18. Prolymphocytic leukemia.
Stone RM
Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
[TBL] [Abstract][Full Text] [Related]
19. B-cell prolymphocytic leukemia: an enduring bona fide entity.
Gonzalez-Mancera MS; Lopategui J; Hoffman D; Kitahara S; Alkan S
Int J Hematol; 2024 May; ():. PubMed ID: 38796826
[TBL] [Abstract][Full Text] [Related]
20. Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy.
Sakhdari A; Tang G; Ginsberg LE; Hirsch-Ginsberg CF; Bueso-Ramos CE; Medeiros LJ; Miranda RN
Case Rep Pathol; 2019; 2019():4915086. PubMed ID: 30941227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]